| LINEAGE CELL THERAP. |
| USA |
| Gesundheit |
| US53566P1093 / A2PP89 |
| BT3 (Frankfurt) |
| FRA:BT3, ETR:BT3, BT3:GR |
| - |
| https://lineagecell.com/ |
|
Lineage Cell Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel allogeneic, or off‑the‑shelf, cell therapies for serious neurological and ophthalmic conditions. The company leverages a proprietary cell-based t..
>Volltext.. |
| 343.1 Mio. EUR |
| 296.67 Mio. EUR |
| 12.61 Mio. EUR |
| -18.26 Mio. EUR |
| -55.04 Mio. EUR |
| -0.24 EUR |
| 2.1 Mio. EUR |
| 35.34 Mio. EUR |
| -16.39 Mio. EUR |
| 4.91 |
| 35.06% |
| -200.92% |
| - |
| - |
| - |
| - |
| LINEAGE CELL |
| 05.04.26 |
|